Clinical trial of piracetam in patients with myoclonus: Nationwide multiinstitution study in Japan

Movement Disorders

Volumn 11, Issue 6, 1996, Pages 691-700

  Ikeda, Akio ^a   Shibasaki, Hiroshi ^a   Tashiro, Kunio ^b   Mizuno, Yoshikuni ^c   Kimura, Jun ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cortical myoclonus; Myoclonus; Piracetam; Progressive myoclonic epilepsy

Indexed keywords

NOOTROPIC AGENT; PIRACETAM;

ABDOMINAL DISCOMFORT; ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; ATTENTION DEFICIT DISORDER; BLOOD DISEASE; CLINICAL TRIAL; CONVULSION; DEPRESSION; DIARRHEA; DROWSINESS; ELECTROPHYSIOLOGY; FATIGUE; FEEDING; FEMALE; GAIT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; MULTICENTER STUDY; MYOCLONUS; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEIZURE; SLEEP DISORDER; WRITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; DISABILITY EVALUATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCLONUS; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; PIRACETAM; TREATMENT OUTCOME;

EID: 0029797919     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110615     Document Type: Article

References (20)

1. Croisile B, Trillet M, Fondarai J, Laurent B, Mauguière F, Billardon M. Long-term and high-dose piracetam treatment of Alzheimer's disease. Neurology 1993;43:301-305.
2. Pepeu G, Spignoli G. Neurochemical actions of "nootropic drugs." In: Wurtman RJ, Corkin S, Growdon JH, Ritter-Walker E, eds. Alzheimer's disease. New York: Raven, 1990:247-252. (Advances in neurology; vol 51).
3. Terwinghe G, Daumerie J, Nicaise C, Rosillon O. Effect therapeutique du piracetam dans un cas de myoclonies d'action post-anoxique. Acta Neurol Belg 1978;78:30-36.
4. Cremieux C, Serratrice G. Myoclonies d'intention et d'action postanxiques: amelioration par le piracetam. Nouv Press Med 1979;41:3357-3358.
5. Papyrakis JC. Management of a case of myoclonia. Acta Ther 1987;13:109-114.
6. Fahn S. New drugs for posthypoxic action myoclonus: observations from a well studied case. Adv Neurol 1986;43: 197-199.
7. Obeso JA, Artieda J, Luquin MR, Vaamonde J, Martinez Lage JM. Antimyoclonic action of piracetam. Clin Neuropharmacol 1986;9:58-64.
8. Obeso JA, Artieda J, Quinn N, et al. Piracetam in the treatment of different types of myoclonus. Clin Neuropharmacol 1988;11:529-536.
9. Brown P, Steiger MJ, Thompson PD, et al. Effectiveness of piracetam in cortical myoclonus. Mov Disord 1993;8:63-68.
10. Ministry of Health and Welfare. GCP handbook: the guideline for clinical practice for trials on medical products. Tokyo: Yakugyo-Jiho, 1990 (in Japanese).
11. Truong DD, Fahn S. Therapeutic trial with glycine in myoclonus. Mov Disord 1988;3:222-232.
12. Ikeda A, Shibasaki H, Nagamine T, et al. Peri-rolandic and fronto-parietal components of scalp-recorded giant SEPs in cortical myoclonus. Electroencephalogr Clin Neurophysiol 1995;96:300-309.
13. Kakigi R, Shibasaki H. Generator mechanisms of giant somatosensory evoked potentials in cortical reflex myoclonus. Brain 1987;110:1359-1373.
14. Rothwell JC, Obeso JA, Marsden CD. On the significance of giant somatosensory evoked potentials in cortical myoclonus. J Neurol Neurosurg Psychiat 1984;47:33-42.
15. Nyback CK, Wiesel FA, Skett P. Effect of piracetam on brain monoamine metabolism and serum prolactin levels in the rat. Psychopharmacol 1979;61:235-238.
16. Chadwick D, Hallett M, Harris R, Jenner P, Reynolds EH, Marsden CD. Clinical, biochemical and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with monoamine oxidase inhibitor, and clonazepam. Brain 1977;100:455-487.
17. Airaksinen EM, Leino E. Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonic epilepsy and its correlation with the decrease of 5HIAA and HVA. Acta Neurol Scand 1982;66:666-672.
18. Growdon JH, Corkin S, Huff FJ, Rosen TJ. Piracetam combined with lecithin in the treatment of Alzheimer's disease. Neurobiol Aging 1986;7:269-276.
19. Inazuki G, Naito H, Ohama E, et al. A clinical study and neuropathological findings of a familial essential myoclonus and epilepsy: the nosological place of familial essential myoclonus and epilepsy. Seishin Shinkeigaku Zasshi 1990;92: 1-21 (in Japanese).
20. Ikeda A, Kakigi R, Funai N, Neshige R, Kuroda Y, Shibasaki H. Cortical tremor: a variant of cortical refelx myoclonus. Neurology 1990;40:1561-1565.